Severe proteinuria during the administration of bevacizumab plus mFOLFOX6 in a colorectal cancer patient after kidney transplantation: a case report

Severe proteinuria during the administration of bevacizumab plus mFOLFOX6 in a colorectal cancer patient after kidney transplantation: a case report

Abstract Background Bevacizumab (BEV) leads to proteinuria and renal damage. It is not clear whether the administration of immunosuppressive drugs after renal transplantation affects the safety of BEV administration. We report a case of severe proteinuria caused by BEV plus 5-fluorouracil, levofolin...

Full description

Bibliographic Details
Main Authors: Ren Onodera, Satoru Nihei, Toshimoto Kimura, Takashi Tomita, Kenzo Kudo
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Kidney transplantation
Tacrolimus
Bevacizumab
Proteinuria
Adverse effects
Colorectal cancer
Online Access:http://link.springer.com/article/10.1186/s40780-020-00175-7

Internet

http://link.springer.com/article/10.1186/s40780-020-00175-7

Similar Items